Weight problems therapies are present process a metamorphosis

by time news

2024-06-10 16:00:09

When Olivier Ziegler, head of the weight problems heart (CSO) on the College Hospital of Nancy (CHRU) and professor of diet on the College of Lorraine, instructed that Stéphane check Wegovy, a brand new weight reduction drug, he didn’t hesitate for a second. It was September 2022. At the moment, this 50-year-old govt (who didn’t wish to give his identify) weighed 145 kilos. The previous athlete, a tall man with a peak of 1.88 meters, stated that he gained weight in years and a sedentary way of life. “Till 100 kilos, I am not fearful. At age 40, I began having hypertension and sleep apnea. I am not even within the temper to placed on my footwear. My BMI [indice de masse corporelle, soit le poids divisé par la taille au carré]He’s 41 years outdated.

On the Web, you learn: weight problems. Superb for this father. His spouse compelled him to attend the CSO of Nancy CHRU. There, his dangerous habits are reviewed. “I’ve realized what a wholesome way of life is, the idea of meals is synonymous with sport, the necessity for train. I went from 2,000 steps to six,000 steps per day. » In eight months, he misplaced 8 kilos. Alas, he introduced them again to relaxation.

Wegovy actually modified your life. With a subcutaneous injection of two.4 mg per week, Stéphane misplaced 25 kilos in eight months. Above all, from the primary days, the sensation of satiety, which has been lacking for a few years, reappears. “Earlier than, I may by no means eat three plates of pasta and 4 scrumptious pancakes. My mind would not say “cease”, he stated. I am unable to inform the distinction between love or need. »

Wegovy is likely one of the latest therapeutic advances in weight problems remedy. Like its massive brother Ozempic (supposed for diabetics), it’s a drug that mimics the hormone glucagon-like peptide-1 (GLP-1), growing its receptor rather more than the pure hormone. The brand new household of medicine, referred to as “GLP-1 analogues”, primarily contains semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda has been approved in France since 2021 however isn’t reimbursed by the Social Safety).

“It isn’t meals components, or a miracle product”

They have an effect on satiety and thus enable higher management of meals consumption. “However watch out, these molecules are usually not love radiators, or a miracle productinstantly warned Karine Clément, professor of diet on the Pitié-Salpêtrière hospital (AP-HP). The remedy should be complete: change of consuming habits, bodily exercise, psychological assist if obligatory…” Most medical trials are carried out on this foundation.

You have got 83.09% of this text left to learn. The remainder is reserved for subscribers.

#Weight problems #therapies #present process #transformation

You may also like

Leave a Comment